Transversus Thoracis Muscle Plane Block for Sternotomy Pain in Cardiac Surgery
1 other identifier
interventional
86
1 country
1
Brief Summary
Sternotomy pain is usually significant after cardiac surgery. Analgesic options for sternotomy in cardiac surgery are often limited. Poorly controlled acute pain is an important factor to development of chronic postsurgical pain. The transversus thoracis muscle plane (TTP) block is a novel technique that provides analgesia to anterior chest wall. A double-blinded RCT is conducted to assess the efficacy of applying TTP block as an adjunct to analgesia in cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2020
CompletedStudy Start
First participant enrolled
October 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 22, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2023
CompletedJuly 13, 2023
July 1, 2023
2 years
October 6, 2020
July 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Opioid consumption
The total amount of opioid (mg) used during the surgery
Once at the end of the surgery
Secondary Outcomes (10)
Percentage blood pressure change
From 5 minutes before skin incision to 10 minutes after skin incision at 1 minute interval ( a total of 15 time point)
Percentage heart rate change
From 5 minutes before incision to 10 minutes after skin incision at 1 minute interval (a total of 15 time points)
Morphine consumption
up to 72 hours postoperatively
Length of hospital stay
Immediately after the surgery up to the day of patient discharge
Intensive Care unit (ICU) stay
Immediately after the surgery up to the time of ICU discharge
- +5 more secondary outcomes
Study Arms (2)
Intervention
ACTIVE COMPARATORUltrasound guided Regional block using 0.25% levobupivacaine (local anaesthetic agent) 20ml (50mg) on each side of the sternum over 1-2 minutes after general anaesthesia before surgery.
Control
PLACEBO COMPARATORUltrasound guided Regional block using 20ml of 0.9% normal saline on each side of the sternum after general anaesthesia before surgery.
Interventions
After general anaesthesia, transversus thoracis plane (TTP) block, a kind of regional block will be performed near both sides of the sternum under ultrasound guidance using either levobupivacaine or normal saline to both groups of patients. The end point for injection is the fluid spread along the plane just superficial to the transversus thoracis muscle, together with the downward displacement of the pleura.
Eligibility Criteria
You may qualify if:
- Elective CABG, aortic valve repair/replacement, mitral valve repair/replacement, or combined CABG/valve procedure
You may not qualify if:
- emergency surgery
- redo surgery
- history of thoracotomy or mastectomy
- history of chronic pain or regular analgesic use (except paracetamol and NSAID)
- history of psychiatric illnesses or illicit drug use
- renal failure with eGFR \<30ml/min or on renal replacement therapy
- mortality or require re-sternotomy within 24h after operation
- intraoperative use of remifentanil
- unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henry Man Kin Wong, MBChB
Chinese University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Honorary Clinical Assistant Professor
Study Record Dates
First Submitted
October 6, 2020
First Posted
October 22, 2020
Study Start
October 15, 2020
Primary Completion
October 22, 2022
Study Completion
April 22, 2023
Last Updated
July 13, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share